Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 26, 2020	Sep. 28, 2019
Current assets:
Cash and cash equivalents	$ 701.0	$ 601.8
Accounts receivable, less reserves of $31.6 and $17.8, respectively	1,028.9	648.7
Inventory	395.1	444.9
Prepaid income taxes	38.8	34.9
Prepaid expenses and other current assets	58.5	62.8
Total current assets	2,222.3	1,793.1
Property, plant and equipment, net	491.5	470.9
Intangible assets, net	1,307.5	1,459.8
Goodwill	2,657.9	2,563.7
Other assets	516.6	154.6
Total assets	7,195.8	6,442.1
Current liabilities:
Current portion of long-term debt	324.9	271.4
Accounts payable	178.8	186.5
Accrued expenses	547.6	430.9
Deferred revenue	186.1	179.5
Finance lease obligation (capital lease obligation in 2019)	1.9	1.8
Total current liabilities	1,239.3	1,070.1
Long-term debt, net of current portion	2,713.9	2,783.6
Finance lease obligation - long term (capital lease obligation in 2019)	17.4	19.2
Deferred income tax liabilities	201.8	275.3
Deferred revenue	12.9	15.8
Other long-term liabilities	303.2	162.4
Commitments and contingencies (Note 13 and 14)
Stockholders’ equity:
Preferred stock, $0.01 par value – 1,623 shares authorized; 0 shares issued	0.0	0.0
Common stock, $0.01 par value – 750,000 shares authorized; 295,107 and 292,323 shares issued, respectively	2.9	2.9
Additional paid-in-capital	5,904.8	5,769.8
Accumulated deficit	(1,573.2)	(2,688.7)
Treasury stock, at cost – 37,609 and 24,639 shares, respectively	(1,579.6)	(926.0)
Accumulated other comprehensive loss	(49.7)	(42.3)
Total Hologic's stockholders’ equity	2,705.2	2,115.7
Noncontrolling interest	2.1	0.0
Total stockholders' equity	2,707.3	2,115.7
Total liabilities and stockholders’ equity	$ 7,195.8	$ 6,442.1